plasma levels of pyridostigmine and/or neostigmine were monitored in 8 myasthenic patients who were stabilised on oral pyridostigmine bromide only ( 60-540 mg per day ) , and in 9 patients who were stabilised on both neostigmine bromide ( 15-480 mg per day ) and pyridostigmine bromide ( 240-1080 mg per day ) , over a period of 12 hr ( 8.00 a.m. - 8.00 p.m. ) .
C0034261
pyridostigmine
C0034262
pyridostigmine bromide